Therefore, we investigated whether TAM polarization was altered in cinobufagin-treated tumors by initially assessing the expression of markers associated with the M1-like (CD80) tumor-suppressive phenotype and the M2-like (CD206) tumor-promoting phenotype. Here, CD80 is linked to neoplasm.